H2L 7905958 [1] |
H37Rv [1] |
Ha 155 [1] |
HA-MRSA [1] |
HAART [2] |
HAART. [1] |
HDAC [1] |
Health Disparity [1] |
Hedgehog [1] |
Hedgehog pathway [1] |
Hedgehog Signaling [1] |
helminthiasis [1] |
helminths [1] |
Hemin [1] |
Hep G2 cell lines [1] |
Hep G2 Cells [1] |
heparin lyase [1] |
Hepatocyte Nuclear Factor 3Beta [1] |
hepatoprotective activity [1] |
HER2 Overexpression [1] |
HER2 positive breast cancer [1] |
herbal medicine [1] |
Hermes Antigen [1] |
Heterocycles [4] |
Heterocyclic [1] |
heterocyclic [1] |
heterocyclic compound [2] |
Heterocyclic compounds [2] |
heterocyclic compounds [1] |
Heterocyclic systems [1] |
HIF-1? [1] |
HIF-1? inhibitor [1] |
High Performance Liquid Chromatography [1] |
Hispanic [1] |
Histone deacetylase [1] |
Histone deacetylases [1] |
Histone H3 [1] |
HIV [3] |
Homogenous Dispersions [1] |
Hormone-dependent breast cancer [1] |
HPLC [1] |
HSP90 [1] |
Hsp90 [1] |
Human [13] |
human [5] |
Human Cell [2] |
Human thymidylate synthase [1] |
Humans [10] |
Hydrogen Bond [1] |
hydrogen bond [1] |
Hydrogen Catalyst [1] |
hydrolase inhibitor [1] |
hydrophobic [1] |
Hydroxychloroquine [1] |
Hydroxycolecalciferol Asian [1] |
hypoxanthine phosphoribosyltransferase [1] |
hypoxanthine phosphoribosyltransferase inhibitor [1] |
Hyssopus officinalis [2] |
Ibufenac [1] |
IC50 [2] |
Ic50 [1] |
IGF-1R [1] |
IGF-1R inhibitors [1] |
Image Analysis [1] |
Imidazo[1,2-a]quinoxaline [1] |
imidazo[1,2-a]quinoxaline [1] |
Imidazotriazine [1] |
Imine pyrazolopyrimidinone [1] |
Imine/amide-imidazole [1] |
immunoblotting [1] |
Immunology [1] |
in silico [1] |
In silico studies [1] |
in silico studies [1] |
in vitro [1] |
in vitro and cell lines [1] |
In Vitro Study [2] |
In vitro study [2] |
in vivo [1] |
in vivo pharmacokinetics [1] |
In-silico [1] |
in-silico; phytoestrogens [1] |
Indazole [1] |
indazole [1] |
India [1] |
Indian [1] |
Indole [3] |
indole [4] |
Indole derivatives [1] |
Indole synthesis [1] |
Indole-benzimidazole hybrids [1] |
Indolealkylamine [1] |
Indolines [1] |
Induced fit [1] |
induced fit [1] |
Inductively Coupled Plasma Mass Spectrometry [1] |
infection [1] |
Inflammation [2] |
inflammatory [1] |
Inhibition [1] |
Inhibitor [1] |
inhibitor [1] |
Inhibitors [1] |
inhibitors [1] |
Inhibitory dose [1] |
Insect Repellent [1] |
Insect Repellents [1] |
Insecticide [1] |
insulin growth factor receptor 1 inhibitor [1] |
Insulin level [1] |
Insulin Resistance [1] |
Insulin resistance [2] |
Insulin. [1] |
interleukin 1 receptor associated kinase 4 [1] |
Interleukin-6 [2] |
Internalization [1] |
Interventions [1] |
Ion [1] |
ipilimumab [1] |
Iproniazid [1] |
IR [1] |
isatin [1] |
isolation [1] |
Isolation And Purification [2] |
Isoprotein [2] |
Isoquinoline [1] |
Isoxazole [2] |
Isoxicam [1] |
Ivl Gene [1] |
Jackfruit Seed Starch [1] |
JAK/STAT3 [1] |
Juniperus macropoda [1] |
K ras protein [1] |
Kappa opioid receptor [1] |
Kaurane Derivative [2] |
Killer cells [1] |
Kinase inhibitors [1] |
kinase inhibitors [1] |
Kinetics [1] |
Knoevenagel condensation [2] |
kz 001 [1] |
kz 02 [1] |
LA-MRSA [1] |
Larva [1] |
Larvicidal [1] |
Larvicidal activity [2] |
Larvicidal activity. [2] |
Leaching [1] |
Legionella pneumophila [1] |
Leptin [1] |
lethargy [1] |
leukemia [1] |
lexibulin [1] |
life cycle [1] |
ligand [1] |
ligand binding [1] |
Lignans [1] |
Lipid profile [1] |
lipophilicity [1] |
Liposome [1] |
Liver Cancer [1] |
liver cell carcinoma [1] |
liver diseases [1] |
Lumiracoxib [1] |
lump [1] |
Lung cancer [2] |
lung cancer [2] |
lysogenic [1] |
Lysophosphatidic Acid Receptor [1] |
lytic [1] |
M. tuberculosis [1] |
Machine learning [1] |
Macrogol [2] |
macromolecule [1] |
Macrophage [1] |
Macrophages [1] |
Major Clinical Study [1] |
Malaria [1] |
Malignancy [1] |
malignant neoplasm [2] |
Mammals [1] |
mandelic acid [1] |
MAO inhibitors [3] |
MAPK [1] |
Mass Fragmentography [1] |
MCF cell lines [1] |
MD simulation [1] |
MDM2-p53 inhibitor [1] |
MDR [2] |
Mechanism [2] |
Mechanism of action [2] |
mechanism of action [2] |
Mechanisms [1] |
Medical Nanotechnology [1] |
Medicinal chemistry [1] |
medicinal chemistry [3] |
medicinal plants [1] |
Medicinal properties [1] |
MEK [1] |
Melanoma [1] |
melanoma [1] |
Melphalan [1] |
Membrane damage [1] |
membrane protein [1] |
Membrane Proteins [1] |
Mental Disease [1] |
Mepacrine [1] |
mercaptopurine [1] |
metabolic disorder [1] |
Metabolism [4] |
metabolism [2] |
Metabotropic Receptor 5 [1] |
metal complexes [1] |
Metal forming nanoparticles [1] |
Metal Nanop s [1] |
metal-free synthesis [1] |
metastatic melanoma [1] |
metastatic uveal melanoma [1] |
Methanol [1] |
method of preparation [1] |
Mice [1] |
Michael reaction [1] |
Microbes [1] |
Microbial Sensitivity Test [1] |
Microglia [1] |
Microrna [1] |
Microscop [1] |
microsomal stability [1] |
Microsponge [1] |
microsponge delivery system [1] |
Microtubule [1] |
Microwave heating [3] |
Minocycline [1] |
mirdametinib [1] |
miscellaneous drugs and agents [1] |
Mitochondria-dependent cell death [1] |
Mitochondrial membrane permeability [1] |
mitochondrial pathway [1] |
Mitochondrion [2] |
mitogen activated protein kinase kinase 1 [1] |
mitogen activated protein kinase kinase 2 [1] |
mitogen activated protein kinase kinase inhibitor [1] |
MLR [1] |
MOA [1] |
Models, Biological [1] |
Molecular Docking [2] |
Molecular docking [9] |
molecular docking [8] |
molecular docking studies [1] |
molecular dynamic simulation [1] |
molecular dynamic simulations [1] |
Molecular Dynamics [2] |
Molecular dynamics [1] |
molecular dynamics [3] |
molecular dynamics simulation [1] |
Molecular dynamics simulations [2] |
molecular dynamics simulations [1] |
molecular dynamics studies [1] |
molecular hybridization [1] |
Molecular Model [1] |
Molecular modeling [5] |
Molecular modelling [4] |
Molecular similarity [1] |
molecular simulation [1] |
Molecular simulations [1] |
Molecular Structure [1] |
molecular weight [1] |
Molecularly Targe [1] |
Molecules [1] |
Monoamine Oxidase [1] |
monoamine oxidase [2] |
Monoamine Oxidase Inhibitor [1] |
Monoamine Oxidase Inhibitors [1] |
monoamineoxidase [1] |
Monoclonal Antibody [2] |
monoclonal antibody [1] |
Monoterpenes [1] |
Mouth Carcinoma [1] |
MRSA [2] |
mTOR pathways [1] |
Mu opioid receptors [1] |
Mulberry [1] |
multi-drug resistance [1] |
multi-target directed ligands [2] |
Multicomponent reactions [1] |
multicomponent reactions [2] |
multidrug resistance [1] |
Multidrug resistance. [1] |
multidrug resistance. [1] |
Multitarget [1] |
Murine double minute 2 (MDM2) [1] |
Mutagenicity [1] |
Mutant EGFR inhibitors [1] |
mutation [1] |
Mutational analysis [1] |
Mycobacterium tuberculosis [1] |
n [2 [(4 hydroxyphenyl)amino] 3 pyridinyl] 4 methoxybenzenesulfonamide [1] |
Naltrexone [1] |
Nano drug delivery [1] |
nano-medicine [1] |
Nanocatalysis [1] |
nanoformulations [1] |
Nanomedical sector [1] |
Nanomedicine [1] |
Nanoparticle (Nps) [1] |
Nanoparticles [3] |
nanosensor [1] |
Nanotoxicology [1] |
Naringenin [1] |
Natural polymers [1] |
Natural products [6] |
natural products [1] |
Naturally occurring fused pyrimidines [1] |
nausea [1] |
NCI [1] |
necrosis [1] |
Neoplasm [2] |
neoplasm [3] |
Neoplasms [3] |
Nepeta cataria [1] |
Nerve Cell Adhesion Molecule L1 [1] |
Nervous System Diseases [1] |
Network model [1] |
neurofibroma [1] |
neurologic disease [1] |
Neurological disorders [1] |
Neuropathic pain [1] |
Neuroprotective agents [1] |
neuroprotective agents [1] |
Neurotransmitters [1] |
New anti-inflammatory chemotypes [1] |
Nf Kappa B Pathway [1] |
nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase 1 [1] |
nimodipine [1] |
Niperotidine [1] |
nitrogen-containing heterocyclic [1] |
nivolumab [1] |
NNRTI [1] |
Nociceptin [1] |
Non human [1] |
Non Insulin Dependent Diabetes Mellitus [1] |
non small cell lung cancer [1] |
Non-covalent EGFR inhibitors [1] |
Non-selective [1] |
Nonh [1] |
Nonhuman [1] |
nonhuman [4] |
Notch pathway [1] |
Notch Receptor [1] |
Notch1 Receptor [1] |
novel drug delivery system [1] |
Novel drug delivery systems [1] |
NRTI [1] |
Nsc 48300 [1] |
NSCLC [2] |
Nsp15 [1] |
Nuclear factor-kappa-B [1] |
Nuclear localization [1] |
Nucleosides [1] |
nutlin [1] |
nutraceutical [2] |
nutrition supplement [1] |
Nyctanthes arbor-tristis [1] |
Obesity [1] |
Oestradiol [1] |
Oestrogen receptors [1] |
OGTT [1] |
Oils, Volatile [1] |
Oligomycin [1] |
ombrabulin [1] |
Oncogene Proteins [1] |
oncoprotein [1] |
ophthalmology [1] |
Opioid [2] |
Oral Absorption [1] |
Oral delivery [1] |
Organic Chemicals [1] |
organic compound [1] |
Organic synthesis [1] |
organocatalysis [2] |
Organochlorines [1] |
Organophosphorus pesticides [1] |
ORL-1 [1] |
Orserdu [2] |
Osteopontin [1] |
Oxazole [1] |
oxazoline [1] |
Oxepinopyrimidines [1] |
Oxidation Reduction Reaction [1] |
Oxidative stress [2] |
Oxyphenbutazone [1] |
Oxyphenisatine [1] |
P Size [1] |
P-coumaric acid [1] |
P-gp [1] |
P53 [1] |
p53 [2] |
Pan PPAR ligands [1] |
pancreas adenocarcinoma [1] |
pancreas cancer [1] |
pancreas metastasis [1] |
PAPYRUS [1] |
Parkinson's disease [1] |
Parkinson’s disease [1] |
Parkinson�s disease [1] |
PARP [1] |
PARP-1 [1] |
PARP-1 inhibitors [1] |
Partial agonist [1] |
particulate matter [1] |
Patients [1] |
PD [1] |
PDE5 [1] |
pembrolizumab [1] |
pentostatin [1] |
Peptide nucleic acids [1] |
Peptide synthesis [1] |
Peptides [1] |
peptides [1] |
Perforins [1] |
peripheral edema [1] |
Peroxisome proliferator-activated receptor [1] |
Pesticides [1] |
Pf 8380 [1] |
phage [1] |
Phagocytosis [1] |
Pharmaceutical Industry [2] |
Pharmaceutical therapy [1] |
Pharmacodynamics [2] |
pharmacodynamics [1] |
Pharmacogenetics [2] |
pharmacokinetic properties [1] |
Pharmacokinetics [2] |
pharmacokinetics [1] |
Pharmacological activities [3] |
Pharmacological activity [1] |
pharmacological activity [1] |
Pharmacophore [2] |
pharmacophore [3] |
Pharmacophore mapping [1] |
pharmacophore mapping [1] |
pharmacophore model [1] |
Pharmacovigilance [1] |
Phase 1 Clinical Trial (Topic) [1] |
Phase 2 Clinical Trial (Topic) [1] |
Phase 3 Clinical Trial (Topic) [1] |
Phenol [1] |
phenol derivative [1] |
Phenylenediamine derivative [2] |
Phosphate [1] |
Phosphodiesterase [1] |
phosphoric acid [1] |
phosphorus [1] |
Phosphotransferase [2] |
Phosphotransferase Inhibitor [1] |
photodynamic [1] |
photoprotective activity [1] |
Photoreception [1] |
Physical and chemical processes [1] |
Physico-chemical characterization [1] |
physicochemical properties [1] |
Physicochemical property [1] |
Physicochemical techniques [1] |
Physiological Functions [1] |
Physiological Models [1] |
Physiology [2] |
phytochemical [1] |
Phytochemicals [3] |
Phytoestrogens [1] |
Phytoestrogens (PEs) [1] |
Phytotherapy [2] |
PI3K [1] |
PI3K/AKT pathway [1] |
Pictet-spengler reaction [1] |
Pictet-spenglerase enzymes [1] |
pictilisib [1] |
PIK3CA [1] |
pimasertib [1] |
Piperazine [1] |
Pirprofen [1] |
PK [1] |
PKM2 inhibitors [1] |
Plant [1] |
Plant Extract [2] |
Plant extract [1] |
Plant Extracts [1] |
Plant Medicinal Product [1] |
Plant Metabolities [1] |
Plant Oils [1] |
Plants [2] |
PLGA nanoparticles [1] |
PLGA-doxorubicin conjugate [1] |
plinabulin [1] |
pMIC [1] |
PNA/DNA duplex [1] |
PNAs [1] |
Podophyllotoxin [1] |
point-of-care test [1] |
Point-of-care testing [1] |
Poloxamer [1] |
Polyethylene Oxides [1] |
Polymers [1] |
Polymersomes [1] |
Polymer�drug conjugation [1] |
Polyol pathway [1] |
Polyphenols [2] |
Potentilla [1] |
Potentilla Atrosanguinea [1] |
Potentilla fulgens [1] |
PPAR gamma [1] |
Preparation technique [1] |
Principal Component Analysis [1] |
Priority Journal [2] |
Proatropisomeric [1] |
Probes [1] |
Process Development [1] |
Process Optimization [1] |
Prodrug [1] |
prodrug [1] |
Prodrugs [1] |
production [1] |
Prolactin [1] |
proliferation [1] |
Prostate [1] |
Prostate cancer [1] |
Proteasome [1] |
proteasome [1] |
protein bcl xl [1] |
Protein Binding [1] |
protein binding [1] |
protein c jun [1] |
protein degradation [1] |
protein domain [1] |
Protein Inhibitor [1] |
protein inhibitor [1] |
Protein Isoforms [1] |
Protein Kinase [2] |
Protein Kinase Inhibitor [1] |
Protein kinase inhibitor [1] |
protein kinase inhibitor [2] |
Protein Kinase Inhibitors [2] |
protein structure [1] |
Protein Tyrosine Kinase [1] |
protein tyrosine kinase inhibitor [1] |
Protein tyrosine phosphatase 1B [1] |
protein tyrosine phosphatase SHP 2 [1] |
Proteinase Inhibitor [1] |
Proteolysis [1] |
proteolysis targeting chimera [2] |
proteosome [1] |
Pseudomonas Aeruginosa [1] |
Punjabi (People) [1] |
purine derivative [1] |
purine uti [1] |
pyran annulated heterocycles [1] |
Pyrazole Derivative [1] |
Pyrazoles [2] |
pyrazolo [3,4] pyrimid [1] |
Pyrazolo[1,5-c]quinazolines [2] |
Pyrazolo[1,5-c]quinazolines and their derivatives [2] |
Pyrazolo[3,4-d]pyrimidine [1] |
pyridine [1] |
Pyrimidine [1] |
pyrimidine [1] |
pyrimidines [2] |
Pyrimidinone derivative [1] |
Pyrimidoazepines [1] |
Pyrimidodiazepines [1] |
pyruvate kinase [1] |
pyruvate kinase M2 [1] |
QSAR [1] |
Quality control [1] |
Quantitative Analysis [2] |
Quantitative Structure Activity R [1] |
Quantitative Structure Activity Relation [1] |
Quantum dot [1] |
quasi emulsion solvent diffusion [1] |
quinazoline [1] |
Quinazoline Derivative [1] |
Quinazolines [2] |
quinolin-2(H)-one [1] |
quinolin-4(H)-one [1] |
Quinoline [2] |
Quinolines [2] |
quinolone [1] |
R. tuberosa [1] |
Racemosides [1] |
Radiation Exposure [1] |
Radical [1] |
radicicol [1] |
Radioactivity [1] |
Radiosensitivity [1] |
RAF [1] |
RAS [1] |
rash [1] |
ravoxertinib [1] |
rdea 119 [1] |
RdRp [1] |
Reaction Analysis [1] |
Reaction mechanism [1] |
Reactive Oxygen Metabolite [1] |
Reactive oxygen metabolite [1] |
Reactive oxygen species [1] |
Rebaudioside A [1] |
rebaudioside A [2] |
Receptor [1] |
Receptors, G-Protein-Coupled [2] |
Redox Effector Factor 1 [1] |
Redox reaction [1] |
Redox sensor [1] |
redox-active [1] |
Reductive cyclization [1] |
refametinib [1] |
Regulation [1] |
Regulatory Authorities [1] |
Regulatory guidelines [1] |
Regulatory toxicology [1] |
remdesivir [1] |
Repurposed drugs [1] |
Resistance [5] |
resistance [1] |
respiratory tract agent [1] |
respiratory tract disease [1] |
Resveratrol [1] |
Retinoic Acid [1] |
reversible MAO inhibitors [2] |
Revertant [1] |
Review [8] |
rhodanine [1] |
RIN analysis [1] |
room temperature [1] |
Rosmarinus officinalis [1] |
RT [1] |
RT-PCR [2] |
Rutoside [1] |
S. rebaudiana [2] |
Saffron [1] |
Salmonella enterica serovar Typhimurium [1] |
Salmonella typhimurium [1] |
SAR [11] |
SARS-CoV-2 [6] |
Scavenger Receptor [1] |
SCLC [2] |
Second generation [1] |
secondary metabolites [1] |
Selective estrogen receptor degraders (SERDs) [1] |
Selective estrogen receptor modulators [1] |
Selectivity [1] |
selumetinib [1] |
Semi-synthetic [1] |
SERD [1] |
Serendipity [1] |
SERM [1] |
SERMs [1] |
Sesquiterpenes [1] |
Seven-membered ring fused pyrimidines [1] |
Shankhpushpi [1] |
Shatavarins [1] |
Shikonin derivatives [1] |
side effect [1] |
Signal Tr [1] |
Signal Transduction [1] |
Signal transduction [1] |
signal transduction [1] |
Signalling [1] |
Signalling pathways [2] |
signalling pathways [1] |
Silver Nanop [1] |
Simulation studies [1] |
Single hit [1] |
Single Nucleotide Polymorphism [1] |
Six-membered ring fused pyrimidines [1] |
Skimmia laureola [1] |
Sodium azide [2] |
Sodium dodecyl sulphate [1] |
solid tumor [1] |
Solubility [1] |
solubility [1] |
solvent injection [1] |
Somatomedin C [1] |
somatomedin C receptor [1] |
Sonic Hedgehog Protein [1] |
Sonidegib [1] |
sorafenib [1] |
Specific antigen [1] |
spectroscopy [1] |
Spectrosocopy [1] |
Spiropyrans [1] |
Sponges [1] |
SSBs [1] |
Stable Dispersions [1] |
Staphylococcus Aureus [1] |
Staphylococcus aureus [2] |
STAT3 protein [1] |
Static Electricity [1] |
Status epilepticus [1] |
Stereochemistry [1] |
Steric Hindrances [1] |
Steroid [1] |
Steroid sulfatase [1] |
steroid sulphatase [1] |
Steroidal alkaloids [1] |
Stevia [2] |
Stevia Rebaudiana [1] |
Steviol [1] |
Stevioside [2] |
Structure Activity Relation [3] |
structure activity relation [1] |
Structure Analysis [1] |
Structure-Activity Relationship [2] |
Structure-activity relationship [1] |
structure-activity relationship [2] |
Structure-activity Relationship. [1] |
structure-based virtual screening [1] |
Sudoxicam [1] |
sulfur [1] |
Sulfur compounds [1] |
Sulindac [1] |
Sulphatase inhibitors [1] |
Sulphonamides [1] |
Surface Active Agents [1] |
Surfactant [2] |
Surfactant-Assisted Dispersion [1] |
Survival Rate [1] |
sustainable developments [2] |
Sustainable release [1] |
Sweetening Agent [2] |
Sweetening Agents [2] |
Synergism [1] |
Synergism. [1] |
Synthesis [16] |
synthesis [2] |
Synthesis (chemical) [1] |
Synthesis Molecular modeling [1] |
SynthesisAryl aldehydes [1] |
Synthetic strategies [1] |
tamoxifen [1] |
tannins [1] |
Targeting [1] |
Targeting. [1] |
Targets [3] |
Taste [2] |
Taste Receptors, Type 1 [1] |
Taste Receptors, Type 2 [1] |
Telomerase [1] |
Terpene [2] |
Terpene Derivative [1] |
Terpenes [1] |
terpenoids [2] |
Tetrahydro-?-carbolines [1] |
Tetrahydrobenzo[b]pyrans [1] |
Tetrahydroimidazopyridines [1] |
Tetrahydroisoquinoline [1] |
tetramer [1] |
tetramerization [1] |
Tetrazole [1] |
Theaflavin 3,3' Digallate [1] |
therapy resistance [1] |
Thiadiazepines [1] |
Thiazole [1] |
Thiazoles [1] |
Thiazolidinedione [1] |
thiazolidinedione [1] |
Thiepinopyrimidines [1] |
thin-film rehydration [1] |
Thio-ether linkage [1] |
Thy 1 Antigen [1] |
Thymidylate synthase [1] |
thyroid hormone [1] |
thyroid hormone-binding proteins [1] |
Thyroid Hormones [1] |
Tienilic Acid [1] |
Tolcapone [1] |
Tolrestat [1] |
Topoisomerase [1] |
Topoisomerase inhibition [1] |
Topoisomerase inhibitors [3] |
Topoisomerases [1] |
Toxicity [3] |
Traditional uses [1] |
trametinib [1] |
transcription factor [1] |
Transcription Factor Nfat [1] |
Transcription Factors [1] |
Translational Research [1] |
translational research [2] |
Trastuzumab [1] |
trastuzumab emtansine [1] |
Trastuzumab. [1] |
Trialkylphosphite [1] |
triple-negative breast cancers [1] |
trisodium citrate dihydrate [1] |
Troglitazone [1] |
Trovafloxacin [1] |
tuberculosis [1] |
Tubulin [3] |
tubulin [2] |
Tubulin Modulators [1] |
Tubulin polymerization inhibitors [1] |
Tumor [1] |
Tumor Necrosis Factor Alpha [1] |
tumour microenvironment [1] |
Type 2 diabetes mellitus [1] |
Tyrosine kinase [2] |
Tyrosine Kinases [1] |
ubiquitin [1] |
ubiquitin protein ligase [1] |
Ubiquitin-Protein Ligases [1] |
Unclassified Drug [2] |
Unclassified drug [3] |
unclassified drug [1] |
unclassified drug binding site [1] |
Unindexed Drug [1] |
United States [1] |
United States Food and Drug Administration [1] |
uprosertib [1] |
urml 3881 [1] |
US FDA approved Fused pyrimidines [1] |
Vaccines [1] |
vaccines [1] |
Vantictumab [1] |
variants [1] |
Vascular Targeting Agent [2] |
Vegetable Oil [1] |
VEGFR-2 [1] |
vemurafenib [1] |
venetoclax [1] |
verubulin [1] |
vibrating orifice aerosol generator [1] |
vinblastine [1] |
Vinca Alkaloid [1] |
vincane [1] |
vincristine [1] |
Vinpocetine [1] |
Virtual screening [1] |
virtual screening [2] |
Vismodegib [1] |
Voglibose [1] |
vomiting [1] |
Water [1] |
Water controlled study [1] |
Western blotting [3] |
Wnt Pathway [1] |
Wnt Protein [1] |
wx 554 [1] |
X Ray Crystallography [1] |
X-ray fluorescence [1] |
X-ray fluorescence imaging research projects [1] |
Xanthine oxidase [2] |
xenograft mice model [1] |
Ximelagatran [1] |
YP2C19*2 [1] |
Zeta Potential [1] |
Zomepirac [1] |
α-amylase [1] |
β-Cells [1] |